GLP1R and metabolic disease: Meanwhile, drugs significantly reduced BMI in females of groups f5 (mice with metabolic disorders and lung emphysema treated with GLP-1) and f6 (mice with metabolic disorders and lung emphysema treated with peg-GLP-1), and males of groups m5 and m6.